Ichor Medical Systems, Inc.

Ichor Medical Systems Inc., a privately-held biotech company founded in San Diego in 1994, is developing products based on the in vivo application of electroporation to enhance intracellular delivery of nucleic acid-based drugs encoding therapeutic proteins, antigens for vaccines, or antibodies for passive immunity, to treat and prevent debilitating or life threatening diseases. Ichor’s proprietary TriGrid Delivery System was the first integrated and fully automated system for electroporation-mediated in vivo nucleic acid administration, enabling total control of the site of injection, placement of electrodes, rate of agent administration, and timing of electroporation delivery. As a result, TriGrid enables the clinical application of electroporation in a manner capable of supporting development and commercialization of nucleic acid-based products.